United States of America
James Symons began his clinical career at Parke-Davis, later Pfizer, where he had primary responsibility for a number of programs that resulted in New Drug Application (NDA) approvals and led efforts for the submission of additional NDAs in the areas of asthma and vaginal atrophy. Symons began his career at the Jackson Laboratory, Bar Harbor, ME, where he conducted research in behavior genetics and he was part of the first program granted funds to develop mouse models of aging.Degrees: M.S. physiological psychology, M.S. biostatistics and research design, Ph.D. epidemiologic science, University of Michigan, Ann Arbor.
Biology & Medicine Drug Designing